BUZZ- Cardiome Pharma Corp: Revenue jumps
** Specialty pharmaceutical company's shares up 6.8 pct at $7.64
** The Canadian company's revenue in the latest quarter jumps to $7.7 million from $107,000 as sales of its new heart drug, Brinavess, continued to rise
** Brinavess, which has won marketing approval in the European Union, Iceland and Norway, is on clinical hold in the United States
** Sales of the company's blood thinner, Aggrastat, is falling due to generic competition
** In the 12 months to Friday's close, the company's stock had more than tripled
© Thomson Reuters 2017 All rights reserved.